Lead Product(s) : Clonixin Lysine
Therapeutic Area : Neurology
Study Phase : Phase III
Sponsor : Pharmagenix
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Lysine Clonixinate is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Low Back Pain.
Product Name : Undisclosed
Product Type : Amino Acid
Upfront Cash : Inapplicable
August 22, 2011
Lead Product(s) : Clonixin Lysine
Therapeutic Area : Neurology
Highest Development Status : Phase III
Sponsor : Pharmagenix
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
